Almirall S.A. announces the opening of a new call for proposals for its AlmirallShare open innovation platform, looking to find partners to identify, validate or test new targets for the treatment of chronic immune-inflammatory diseases of the skin.
These diseases — including psoriasis, atopic dermatitis and pemphigus vulgaris — have significant comorbidities that have a profound impact on the quality of life of those affected, and new treatments continue to be needed.
The latest call for entries — Immune-inflammatory Diseases Under Your Skin — will be open from July 25 to October 31, 2019, and is a call to institutions, such as universities, research centers, and start-up biotechnology or pharmaceutical companies worldwide with an interest in pharmaceutical R&D to submit original research ideas.
Selected proposals will be awarded grants and access to scientific support for their research.
Applications from individual healthcare providers will not be considered for this collaboration project. For more information and to submit a proposal, visit Almirall.
[Source(s): Almirall, PR Newswire]
